| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |